<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03090113</url>
  </required_header>
  <id_info>
    <org_study_id>2014ZX09201022-010-11</org_study_id>
    <nct_id>NCT03090113</nct_id>
  </id_info>
  <brief_title>Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism</brief_title>
  <acronym>SPACE</acronym>
  <official_title>A Random, Double-blind, Parallel, Placebo-controlled, Multi-center Study of Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ministry of Science and Technology of the People´s Republic of China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ministry of Science and Technology of the People´s Republic of China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double blind, placebo-controlled, parallel, multicenter research in
      order to evaluate the effect of Shuxuetong injection in prevention of symptomatic or
      asymptomatic new cerebral infarction within 10 days.

      Subgroup study：Evaluate the role of advanced diagnostic technique in identifying potential
      causes of Embolic Stroke of Undetermined Source (ESUS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Shuxuetong injection or Placebo injection for 10days. About 2416 patients randomized at 80
      centers all over China with 20 subgroup study centers.

      Face to face interview at baseline, 10 days, and 90 days.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 12, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptomatic or Asymptomatic New Cerebral Infarction</measure>
    <time_frame>10 days</time_frame>
    <description>Those patients who are still alive at 10 days after randomization will be contacted to set up a follow-up clinical visit. Information of recurrent symptomatic cerebral infarction will be collected and MRI examination will be performed to detect asymptomatic new cerebral infarction.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptomatic Cerebral Infarction</measure>
    <time_frame>10 days</time_frame>
    <description>Those patients who are still alive at 10 days after randomization will be contacted to set up a follow-up clinical visit. Information of recurrent symptomatic cerebral infarction will be collected.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asymptomatic Cerebral Infarction</measure>
    <time_frame>10 days</time_frame>
    <description>Those patients who are still alive at 10 days after randomization will be contacted to set up a follow-up clinical visit. MRI examination including diffusion weighted imaging (DWI) sequence will be performed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral Infarction Volume Expansion</measure>
    <time_frame>10 days</time_frame>
    <description>Those patients who are still alive at hospital discharge will be contacted to set up a follow-up clinical visit. MRI examination will be performed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NIHSS Score Increase</measure>
    <time_frame>10 days</time_frame>
    <description>Those patients who are still alive at hospital discharge will be contacted to set up a follow-up clinical visit. Neurological and functional assessments including NIHSS will be performed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent Symptomatic Stroke(Cerebral infarction, cerebral hemorrhage)</measure>
    <time_frame>90 days</time_frame>
    <description>Those patients who are still alive at 90days after onset will be contacted by telephone to set up a follow-up clinical visit. Information of recurrent symptomatic stroke will be collected.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent Symptomatic Ischemic Stroke</measure>
    <time_frame>90 days</time_frame>
    <description>Those patients who are still alive at 90days after onset will be contacted by telephone to set up a follow-up clinical visit. Information of recurrent symptomatic ischmemic stroke will be collected.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Combined Vascular Events</measure>
    <time_frame>90 days</time_frame>
    <description>Combined Vascular Events was defined as a combination of symptomatic stroke, myocardial infarction and vascular death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability or Death</measure>
    <time_frame>90 days</time_frame>
    <description>Disability or Death was defined as a score of 3 to 6 on the modified Rankin Scale at 90days after onset.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Detected an Atrial Fibrillation Persistent ≥ 30s</measure>
    <time_frame>90 days</time_frame>
    <description>Pre-specified Outcomes for Substudy of 'Etiology Study in Patients with ESUS'</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2416</enrollment>
  <condition>Embolic Stroke</condition>
  <arm_group>
    <arm_group_label>Shuxuetong Injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Shuxuetong Injection,12ml,ivgtt,day1; Shuxuetong Injection,6ml,ivgtt,day2 to day10;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Injection,12ml,ivgtt,day1; Placebo Injection,6ml,ivgtt,day2 to day10;</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Shuxuetong Injection</intervention_name>
    <description>intravenous drip</description>
    <arm_group_label>Shuxuetong Injection</arm_group_label>
    <other_name>Shuxuetong</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Injection</intervention_name>
    <description>intravenous drip</description>
    <arm_group_label>Placebo Injection</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          1. More than or equal to 18 years old and less than 80 years old;

          2. Acute ischemic stroke, brain magnetic resonance imaging showed non lacunar infarction
             (subcortical infarction less than or equal to 1.5 cm);

          3. Onset within 72 hours;

          4. Patients or their family members are willing to sign the informed consent.

        Exclusion criteria

          1. Intracranial hemorrhage: cerebral hemorrhage, subarachnoid hemorrhage, etc.;

          2. Transient ischemic attack;

          3. Lacunar infarction;

          4. History of acute stroke within 6 months;

          5. Clear diagnosis of other causes of ischemic stroke (arterial dissection, arteritis,
             vasospasm, etc.);

          6. The acute infarcts lesion more than one-half lobe in size;

          7. Preceding modified Rankin Scale (mRS) score ≥ 2;

          8. Cumulative usage of traditional Chinese medicine which activating blood circulation
             more than 3 times after onset, including but not limited to: Danhong, Xueshuantong,
             Xuesaitong, Ginkgo biloba, sodium ozagrel, Salvia miltiorrhiza, ligustrazine, Erigeron
             breviscapus, etc;

          9. Chronic liver disease, liver and kidney dysfunction, lifted alanine aminotransferase
             (＞3 times the ULN), lifted serum creatinine (＞2 times the ULN）;

         10. History of coagulopathy, systemic bleeding, thrombocytopenia or neutropenia;

         11. Blood pressure ＞90/60 mmHg or ≤220/120 mmHg after treatment;

         12. Serious heart or lung disease, in the judgment of clinical study staff, would not
             suitable to participant in the trial;

         13. Patients with atrial fibrillation who were scheduled or likely to receive
             anticoagulant therapy with unfractionated heparin or low molecular weight heparin
             within 2 weeks after randomization

         14. A medical condition likely to limit survival to less than three months or any other
             condition judged by the clinic team to likely limit the adherence to study procedures;

         15. Known allergies for ingredients of the drug, allergy history for food or drug;

         16. Pregnant, currently trying to become pregnant, or of child-bearing potential and not
             using birth control;

         17. Participation in another clinical trial within 30 days;

         18. Unable to understand and/or comply with the study procedures and/or follow-up studies
             due to mental illness, cognitive or emotional disorders.

        Subgroup Exclusion Criteria

          1. History of atrial fibrillation

          2. Atrial fibrillation in 12-lead electrocardiogram (ECG);

          3. Heart rate monitoring (dynamic electrocardiogram telemetry) up to 20 hours or more
             detected atrial fibrillation for 6 minutes or more;

          4. Intracardiac thrombosis in thoracic or esophageal echocardiography;

          5. Occlusion or proximal vessel infarction for more than 50%.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wang yongjun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tian Tan Hospital, Capital Medical University, Beijing, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wang yilong, MD</last_name>
    <phone>00861067013383</phone>
    <email>yilong528@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meng xia, MD</last_name>
    <phone>00861067096699</phone>
    <email>mengxia45@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wuhu No.1 People's Hospital</name>
      <address>
        <city>Wuhu</city>
        <state>Anhui</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Houqin Chen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Tian Tan Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xia Meng, Phd</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ansteel Group Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guimei Zhao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beiujing Fengtai Youanmen Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shiyong Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Fangshan District</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianhua Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yongchuan hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weiwu Zou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Houjie Hospital</name>
      <address>
        <city>Dongguan</city>
        <state>Guangzhou</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhizhong Mei</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cangzhou Peoole's Hospital</name>
      <address>
        <city>Cangzhou</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanling Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Hejian</name>
      <address>
        <city>Cangzhou</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanxia Wang</last_name>
      <phone>People's Hospital of Hejian</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuancheng County Hospital</name>
      <address>
        <city>Chengde</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinsheng Tao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Traditional Chinese Medicine Hospital of Qiu County</name>
      <address>
        <city>Handan</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Sun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hengshui Fourth Hospital</name>
      <address>
        <city>Hengshui</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aisheng Wu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jizhou District Hospital of Hengshui</name>
      <address>
        <city>Hengshui</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linying Gui</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shijiazhuang Pingan Hospital Affiliated to Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongying Sun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huijuan Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Jiamusi University</name>
      <address>
        <city>Jiamusi</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhi Yang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Heilongjiang Province Agricultural Reclamation Mudanjiang Authority Central Hospital</name>
      <address>
        <city>Mudanjiang</city>
        <state>Heilongjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaofan Yang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Handan Municipal Center Hospital</name>
      <address>
        <city>Handan</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinping Liu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of University of South China</name>
      <address>
        <city>Hengyang</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shanqing Yi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Zhongmu</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mingzhi Zhao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhengzhou Yihe Hospital Affiliated to Henan University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Xu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jingmen City Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Jingmen</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wuhan NO.1 Hospital,Wuhan Hospital Of Traditional Chinese And Western Medicine</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guohua Chen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jiangsu Province Hospital of TCM</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Minghua Wu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nantong 3rd People's Hospital</name>
      <address>
        <city>Nantong</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Panbing Huang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhangjiagang First People's Hospital</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiuyi Wu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhangjiagang Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Chinese Medicine</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yaming Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Xuzhou Medical College</name>
      <address>
        <city>Xuzhou</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deqin Geng</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jiangxi Provincial People's Hospital</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinhui Qu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Jilin University-the Eastern Division</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hui Zhu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Huludao</name>
      <address>
        <city>Huludao</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yefang Feng</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jinzhou Medical University</name>
      <address>
        <city>Jinzhou</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lianqiu Min</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Baotou Medical College</name>
      <address>
        <city>Baotou</city>
        <state>Neimenggu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongying Sun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wu Yuan People's Hospital</name>
      <address>
        <city>Bayan Nur</city>
        <state>Neimenggu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yongming Chen</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Chifeng University</name>
      <address>
        <city>Chifeng</city>
        <state>Neimenggu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanru Zhao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Huimin People's Hospital</name>
      <address>
        <city>Binzhou</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dengling Wang</last_name>
      <phone>17754329809</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ningjin County People's Hospital</name>
      <address>
        <city>Dezhou</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingjun Han</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Western Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qinghua Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Western Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maolin Hao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Penglai</name>
      <address>
        <city>Penglai</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guiru Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Qingdao West Coast New Area</name>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiangting Chai</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Qingdao Haci medical group hospital</name>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruiyou Guo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Qingdao University</name>
      <address>
        <city>Qingdao</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xudong Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>First Hospital of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoyuan Niu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Shenzhen</name>
      <address>
        <city>Shenzhen</city>
        <state>Shenzhen</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lijie Ren</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dongyang People's Hopital</name>
      <address>
        <city>Dongyang</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dongjuan Xu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lishui People's Hospital</name>
      <address>
        <city>Lishui</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Likang Lan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>No.1 People's Hospital of Taizhou</name>
      <address>
        <city>Taizhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhimin Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ruian People's Hospital</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuerong Huang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2017</study_first_submitted>
  <study_first_submitted_qc>March 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2017</study_first_posted>
  <last_update_submitted>November 20, 2017</last_update_submitted>
  <last_update_submitted_qc>November 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ministry of Science and Technology of the People´s Republic of China</investigator_affiliation>
    <investigator_full_name>yongjun wang</investigator_full_name>
    <investigator_title>Vice President of Beijing Tiantan Hospital</investigator_title>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Embolic Stroke</keyword>
  <keyword>Shuxuetong</keyword>
  <keyword>Recurrence</keyword>
  <keyword>Symptomatic New Cerebral Infarction</keyword>
  <keyword>Asymptomatic New Cerebral Infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

